Related Experiment Video
Updated: May 23, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Interventional therapies for hepatocellular carcinoma.
Jonathon M Willatt1, Isaac R Francis, Paula M Novelli
1University of Michigan, 1500 E Medical Center Drive, Ann Arbor, MI 48109, USA. jwillatt@med.umich.edu
Summary
Hepatocellular carcinoma (HCC) is a leading cause of cancer death. Recent staging systems help guide multidisciplinary treatment, including minimally invasive image-guided therapies performed by radiologists.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Hepatocellular carcinoma (HCC) represents a significant global health burden, ranking as the third leading cause of cancer-related mortality worldwide.
- The evolution of cancer care has led to the development of sophisticated staging systems for HCC.
- These systems are crucial for stratifying patients within multidisciplinary treatment frameworks.
Purpose of the Study:
- To highlight the role of recent advancements in HCC staging.
- To emphasize the integration of minimally invasive image-guided therapies into HCC management.
- To underscore the critical contribution of radiologists in delivering these advanced treatments.
Main Methods:
- Review of current HCC staging systems.
- Analysis of treatment algorithms incorporating staging data.
- Examination of minimally invasive image-guided therapy techniques relevant to HCC.
Main Results:
- Staging systems effectively stratify HCC patients for tailored treatment.
- Minimally invasive image-guided therapies are increasingly integral to HCC management.
- Radiologists are key providers of these image-guided interventions.
Conclusions:
- Modern HCC staging facilitates personalized, multidisciplinary care.
- Minimally invasive image-guided therapy offers a vital treatment modality for HCC.
- The expertise of radiologists is essential for the successful implementation of image-guided HCC treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...